16 April 2009 – Case of the Week #143
This email is only sent to subscribers. To subscribe or unsubscribe to this or our other email lists, send an email to [email protected], indicating subscribe or unsubscribe to [name of email]. Our other email lists are:
● Pathologist/PhD jobs - biweekly
● Other laboratory jobs - biweekly
● Pathology fellowships - biweekly
● Pathology website news - monthly
● Pathology new books - monthly
● The Detroit College Promise - the charity we sponsor (monthly)
For our DermatologyOutlines.com website, we have these email lists:
● Dermatologist jobs / Practice openings - biweekly
● Dermatology fellowships - biweekly
● Dermatology website news - monthly
● Dermatology new books - monthly
We have extensively updated Kidney tumors, and split the topic into two smaller chapters, which will now be updated annually:
These chapters have two tables of contents - one sorted in the usual manner and one in alphabetical order. Each chapter now has hundreds of images from the AFIP fascicle - third series, which include the description as part of the image. For some images, you should click on the image once to enlarge it to read the descriptions more easily. We also added many other new images and references, more spacing to improve readability, and more text labels. Let us know if you have any comments.
We have added a new Management Page article - CMS Continues to Tinker with Anti-Markup Rule, POD Labs and In-Office Histology Labs in the Cross-Hairs, by John Outlaw, PSA, LLC. Click here for the article or you can access the Management Page from the center section of our Home Page.
To view the images or references in this Case of the Week, you must click on the links in blue. Links in green are to journals with free full text-no registration. You can also access these cases by visiting our Home Page, then click on the Case of the Week button on the left hand side.
Thanks to Dr. David Cohen, Herzliya Medical Center, Israel, for contributing this case. To contribute a Case of the Week, email [email protected] with the clinical history, your diagnosis and diagnostic microscopic images (textbook quality) in JPG, GIF or TIFF format (send as attachments, we will shrink if necessary). Please include any other images (gross, immunostains, etc.) that may be helpful or interesting. We will write the discussion (unless you want to), list you as the contributor, and send you $35 (US dollars) by check or PayPal for your time after we send out the case. Please only send cases with high quality images and a diagnosis that is somewhat unusual (or a case with unusual features).
Case of the Week #143
A 37 year old woman with no significant medical history was admitted for abdominal pain. Physical exam revealed a large mobile upper abdominal mass. Laboratory results as well as tumor markers were all within the normal range.
A laparotomy revealed a 20 x 15 cm, upper abdominal, highly vascularized and necrotic mass, that appeared to originate from the head of the pancreas. It was attached to the transverse mesocolon, stomach, portal vein and superior mesenteric vessels. An en-block resection of the mass with the head of the pancreas, transverse colon, and the mesentery was performed.
The mass was composed of grey-white solid tissue with large regions of yellow-grey necrosis. It was enclosed in a fibrous capsule with a peripheral rim of lymphoid tissue, suggesting the tumor had replaced a lymph node. The tumor had infiltrated the capsule and extended up to the excision margin.
What is your diagnosis?
The tumor showed large zones of necrosis, with interspersed nests of malignant cells, which showed marked cellular pleomorphism and mitotic activity. The cells had clear to eosinophilic cytoplasm, with large vesicular nuclei and prominent eosinophilic nucleoli. Focally, there were areas showing a brown “dusty” pigment suggestive of melanin. There was no glandular growth or sarcomatous features.
The tumor cells were strongly immunoreactive for Melan A and HMB-45, weakly positive for EMA and had focal weak positivity for S100. Tumor cells were negative for CD68, Pan-keratin, LCA, CD117 and inhibin. There was no clinical history of a prior melanoma or other tumor. These findings are consistent with a perivascular epithelioid cell tumor (PEComa), originating from the transverse mesocolon and infiltrating lymphatic structures and its capsule. The diagnosis was confirmed by Dr. Christopher Fletcher (Harvard Medical School).
The concept of a perivascular epithelioid cell tumor was first proposed by Bonetti in 1992 (AJSP 1992;16:307). This tumor family includes angiomyolipoma (renal and extrarenal), clear cell “sugar” tumor (lung and extrapulmonary), lymphangioleiomyomatosis, and related tumors of the falciform ligament / ligamentum teres, skin (Histopathology 2005;46:498), uterus (Mod Path 2005;18:1336) and other viscera and soft tissue. There is no known normal counterpart to the perivascular epithelioid cell.
Histologically, these tumors are composed of epithelioid and spindle cells with immunoreactivity for melanocytic markers such as HMB-45 and Melan A, and myogenic markers such as actin (Int J Surg Pathol 2009 Jan 4 [epub ahead of print]). They are usually positive for CD1a (Pathol Int 2008;58:169).
The differential diagnosis is broad, and includes melanoma, GIST tumors, clear cell sarcoma of soft parts, alveolar soft part sarcoma, leiomyosarcoma and even paraganglioma (AJSP 2009;33:475). In general, thorough sampling of the tumor, use of melanocytic markers and other immunostains, and possibly molecular markers for characteristic cytogenetics will differentiate these disorders.
Nat Pernick, M.D., President
30100 Telegraph Road, Suite 408
Bingham Farms, Michigan (USA) 48025
Email: [email protected]
Alternate email: [email protected]